A detailed history of Venturi Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 6,025 shares of BMY stock, worth $361,198. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,025
Previous 2,898 107.9%
Holding current value
$361,198
Previous $149,000 128.19%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$51.92 - $59.94 $162,353 - $187,432
3,127 Added 107.9%
6,025 $340,000
Q3 2024

Nov 04, 2024

BUY
$39.66 - $51.75 $61,790 - $80,626
1,558 Added 116.27%
2,898 $149,000
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $5,192 - $6,835
129 Added 10.65%
1,340 $55,000
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $16,073 - $18,224
335 Added 38.24%
1,211 $65,000
Q4 2023

Jan 23, 2024

BUY
$48.48 - $57.85 $6,496 - $7,751
134 Added 18.06%
876 $44,000
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $405 - $453
-7 Reduced 0.93%
742 $43,000
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $1,019 - $1,131
-16 Reduced 2.09%
749 $47,000
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $50,268 - $57,015
765 New
765 $53,000
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $498,205 - $552,077
-8,675 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $124,989 - $146,125
2,280 Added 35.65%
8,675 $510,000
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $280,256 - $407,277
6,040 Added 1701.41%
6,395 $356,000
Q3 2019

Oct 29, 2019

BUY
$42.77 - $50.71 $15,183 - $18,002
355 New
355 $18,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Venturi Wealth Management, LLC Portfolio

Follow Venturi Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.